This chemokine receptor can position CD8+ cytotoxic T lymphocytes (CTL) in perivascular niches in the tumor stroma, which is enriched in DC3 (CCR7+ DC) expressing the ligand of CXCR6, CXCL16. Here, CD8A is linked to neoplasm.